Cargando…
Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI)
The pathogenesis of ST-elevation myocardial infarction (STEMI) involves plaque disruption, platelet aggregation and intracoronary artery thrombus formation. Aspirin is the cornerstone of antiplatelet therapy in patients with STEMI, reducing the risk of recurrent myocardial infarction or death during...
Autores principales: | Tran, Huyen, Mehta, Shamir R, Eikelboom, John W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1994022/ https://www.ncbi.nlm.nih.gov/pubmed/17323592 |
Ejemplares similares
-
COVID-19 Pneumonia: ST-segment Elevation Myocardial Infarction (STEMI) and Myocarditis
por: Ali, Azhar, et al.
Publicado: (2020) -
Small-Vessel Vasculitis After ST-Segment Elevation Myocardial Infarction: Clopidogrel or Amiodarone?
por: Lehr, Saskia, et al.
Publicado: (2022) -
Is ST-segment elevation myocardial infarction (STEMI) always STEMI? Case report of a rare cause of an electric storm
por: Wojtasik-Bakalarz, Joanna, et al.
Publicado: (2020) -
Lysophospholipids as Predictive Markers of ST-Elevation Myocardial Infarction (STEMI) and Non-ST-Elevation Myocardial Infarction (NSTEMI)
por: Chorell, Elin, et al.
Publicado: (2020) -
LASSO Regression-Based Diagnosis of Acute ST-Segment Elevation Myocardial Infarction (STEMI) on Electrocardiogram (ECG)
por: Wu, Lin, et al.
Publicado: (2022)